Skip Navigation

INT23-14-01, Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction RENAISSANCE: A Phase II Single Arm Trial

Brief Summary

Type:
Other

Study Type:
Prevention

Phase:
II

ClinicalTrials.gov Identifier:
NCT06184750

Study #:
STUDY00160308

Start Date:
Jan 10, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06184750

View Complete Trial Details & Eligibility at ClinicalTrials.gov